Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Other Non-Current Assets: 2019-2025

Historic Other Non-Current Assets for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to $9.7 million.

  • Harmony Biosciences Holdings' Other Non-Current Assets rose 55.15% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 55.15%. This contributed to the annual value of $6.2 million for FY2024, which is 2.25% down from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Other Non-Current Assets stood at $9.7 million, which was up 77.35% from $5.5 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Other Non-Current Assets registered a high of $9.7 million during Q3 2025, and its lowest value of $750,000 during Q1 2021.
  • Its 3-year average for Other Non-Current Assets is $5.6 million, with a median of $6.2 million in 2024.
  • Data for Harmony Biosciences Holdings' Other Non-Current Assets shows a peak YoY increase of 368.67% (in 2021) and a maximum YoY decrease of 47.11% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Harmony Biosciences Holdings' Other Non-Current Assets stood at $3.5 million in 2021, then decreased by 20.40% to $2.8 million in 2022, then spiked by 125.09% to $6.3 million in 2023, then dropped by 2.25% to $6.2 million in 2024, then surged by 55.15% to $9.7 million in 2025.
  • Its Other Non-Current Assets was $9.7 million in Q3 2025, compared to $5.5 million in Q2 2025 and $5.9 million in Q1 2025.